[HTML][HTML] The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
The recent outbreak of the corona virus disease (COVID-19) has had major global impact.
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …
The relationship between severe acute respiratory syndrome coronavirus (SARS-CoV-2) …
Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease
Q Su, T Li, GW Liu, YL Zhang, JH Guo… - Neural Regeneration …, 2023 - journals.lww.com
Agomelatine is a selective agonist of melatonin receptor 1A/melatonin receptor 1B (MT 1/MT
2) and antagonist of 5-hydroxytryptamine 2C receptors. It is used clinically to treat major …
2) and antagonist of 5-hydroxytryptamine 2C receptors. It is used clinically to treat major …
The melatonin receptor agonist agomelatine protects against acute pancreatitis induced by cadmium by attenuating inflammation and oxidative stress and modulating …
Pancreatitis is a serious effect of the heavy metal cadmium (Cd) and inflammation and
oxidative stress (OS) are implicated in Cd-induced pancreatic injury. This study evaluated …
oxidative stress (OS) are implicated in Cd-induced pancreatic injury. This study evaluated …
Cadmium cardiotoxicity is associated with oxidative stress and upregulated TLR-4/NF-kB pathway in rats; protective role of agomelatine
Cardiotoxicity is one of the hazardous effects of the exposure to the heavy metal cadmium
(Cd). Inflammation and oxidative injury are implicated in the cardiotoxic mechanism of Cd …
(Cd). Inflammation and oxidative injury are implicated in the cardiotoxic mechanism of Cd …
Artificial and natural interventions for chemotherapy-and/or radiotherapy-induced cognitive impairment: A systematic review of animal studies
LE Kuil, T Varkevisser, MH Huisman, M Jansen… - Neuroscience & …, 2023 - Elsevier
Background Cancer survivors frequently experience cognitive impairments. This systematic
review assessed animal literature to identify artificial (pharmaceutical) or natural …
review assessed animal literature to identify artificial (pharmaceutical) or natural …
Efficacy of repetitive transcranial magnetic stimulation and agomelatine on sleep quality and biomarkers of adult patients with mild to moderate depressive disorder
Z Pu, Q Hou, H Yan, Y Lin, Z Guo - Journal of Affective Disorders, 2023 - Elsevier
Background Mild to moderate depressive disorder (DD), which accounts for much larger
patient population, has been largely neglected in previous studies exploring the sleep …
patient population, has been largely neglected in previous studies exploring the sleep …
RETRACTED: Melatonin rescues the mice brain against cisplatin-induced neurodegeneration, an insight into antioxidant and anti-inflammatory effects
Figure 1C appears similar to Figure 5h of the article published by Oxidative Medicine and
Cellular Longevity 2021 (2021) Article ID 6635552 https://doi. org/10.1155/2021/6635552 …
Cellular Longevity 2021 (2021) Article ID 6635552 https://doi. org/10.1155/2021/6635552 …
Agomelatine: a potential multitarget compound for neurodevelopmental disorders
R Savino, AN Polito, G Marsala, A Ventriglio… - Brain Sciences, 2023 - mdpi.com
Agomelatine (AGM) is one of the latest atypical antidepressants, prescribed exclusively for
the treatment of depression in adults. AGM belongs to the pharmaceutical class of melatonin …
the treatment of depression in adults. AGM belongs to the pharmaceutical class of melatonin …
Agomelatine attenuates cisplatin-induced cognitive impairment via modulation of BDNF/TrkB signaling in rat hippocampus
Cisplatin is a drug used effectively in the treatment of malignant tumors. However, cisplatin
has many side effects, including cognitive impairment. Agomelatine, a synthetic melatonin …
has many side effects, including cognitive impairment. Agomelatine, a synthetic melatonin …
Brain protection by Methylene blue and its derivative, Azur B, via activation of the Nrf2/ARE pathway in cisplatin-induced cognitive impairment
EP Krutskikh, DV Potanina, NA Samoylova… - Pharmaceuticals, 2022 - mdpi.com
Cisplatin is a cytotoxic chemotherapeutic drug that leads to DNA damage and is used in the
treatment of various types of tumors. However, cisplatin has several serious adverse effects …
treatment of various types of tumors. However, cisplatin has several serious adverse effects …